Biostage Inc (OTCMKTS:BSTG) Stock In Focus After Chairman and CEO Transition

Clinical stage biotech firm Biostage Inc (OTCMKTS:BSTG) made a significant announcement yesterday which could bring it on to the radars of investors in a big way this morning and investors could do well to take a closer look. The company announced yesterday that it had appointed its existing board member Jerry He as its Chairman of the Board and also the Chief Executive Officer.

Trading Data

On Wednesday, BSTG stock ended flat at $6 with more than 71 shares, compared to volume of 1.27K shares. The stock moved within a range of $6.00 – 6.00 after opening trade at $6.10.

Biostage Announces Chairman and CEO Transition

The appointment went into effect immediately. It should also be noted in this regard that He had been a member of the company’s board since as far back as November 2021. He is going to replace David Green, who is moving away from the two roles but at the same time would continue to serve on the company’s board.

Green is also going to help He in making the transition to his role as the Chief Executive Officer. Up until February this year, He had been the Executive Vice Chairman of Bright Scholar Education Holdings Limited and had also been the Chief Executive Officer of the company previously.

He had been involved in wealth management in the past and also holds considerable experience in the biotech and pharmaceutical sectors. It remains to be seen if there is any move on the Biostage stock today.